Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-20-004009

Options or other derivatives

  • Chief Commercial Officer acquired 70,517 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Marek David C Chief Commercial Officer 2020-03-17 Grant or award · Employee Stock Option (Right to Buy) +53,984 53,984 D
Marek David C Chief Commercial Officer 2020-03-17 Grant or award · Restricted Stock Units +16,533 16,533 D
Loading xslF345X03/edgar.xml…